Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Several companies and labs are betting the latest generation of chatbots could make useful research assistants, accelerating ...
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...
Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Louisville Public Media on MSN1d
COVID-19 tests, variants and updated vaccines: Here’s what you need to knowThe newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...
BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who ...
The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...
Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of ...
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback